STOCK TITAN

[Form 3] Phathom Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Initial Form 3 filed for Sanjeev Narula. The filing reports a Date of Event of 10/06/2025 and identifies the reporting person as Sanjeev Narula with an address at 100 Campus Drive, Suite 102, Florham Park, NJ 07932. The form indicates the reporting person is an Officer with the title Chief Financial & Bus. Officer. The report discloses no non-derivative or derivative securities beneficially owned (listed as 0 and no securities are beneficially owned). The signature on the filing is by an attorney-in-fact dated 10/07/2025.

Modulo Iniziale 3 presentato per Sanjeev Narula. Il deposito riporta una Data dell'Evento di 10/06/2025 e identifica la persona che presenta la dichiarazione come Sanjeev Narula con un indirizzo in 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Il modulo indica che la persona che presenta la dichiarazione è un Officer con il titolo Direttore Finanziario e Responsabile delle Attività. Il rapporto dichiara nessuno di titoli non derivati o derivati detenuti in modo vantaggioso (elencati come 0 e nessun titolo è detenuto in modo vantaggioso). La firma della presentazione è di un procuratore ad acta datata 10/07/2025.

Formulario Inicial 3 presentado para Sanjeev Narula. La presentación informa una Fecha del Evento de 10/06/2025 e identifica a la persona informante como Sanjeev Narula con una dirección en 100 Campus Drive, Suite 102, Florham Park, NJ 07932. El formulario indica que la persona informante es un Funcionario con el título Director Financiero y de Negocios. El informe revela ninguna tenencia ventajosa de valores no derivados ni derivados (enumerados como 0 y ningún valor es ventajosamenteposeído). La firma del archivo es realizada por un apoderado con fecha 10/07/2025.

사니조브 나루라를 위한 초기 양식 3 제출. 제출서는 사건 날짜10/06/2025로 보고하며 보고자는 Sanjeev Narula로 식별되고 100 Campus Drive, Suite 102, Florham Park, NJ 07932에 주소가 있습니다. 양식은 보고자가 임원이며 직함은 재무 책임자 및 비즈니스 책임자임을 명시합니다. 보고서는 없음의 비파생 또는 파생 증권을 실질적으로 소유하지 않는다고 밝히며(목록에 0, 자산이 실질적으로 보유되지 않음으로 표시). 서명은 대리인2025-10-07자로 이루었습니다.

Formulaire initial 3 déposé pour Sanjeev Narula. Le dépôt indique une Date de l'Événement de 10/06/2025 et identifie la personne qui dépose comme Sanjeev Narula avec une adresse au 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Le formulaire indique que la personne déclarante est un Fonctionnaire avec le titre Directeur Financier et Responsable des Activités. Le rapport indique aucun titre détenu de manière bénéficiaire tant pour des valeurs non dérivées que dérivées (énumérés comme 0 et aucune valeur n’est détenue de manière bénéficiaire). La signature sur le dépôt est apposée par un mandataire daté du 10/07/2025.

Initial Form 3 eingereicht für Sanjeev Narula. Die Einreichung meldet ein Datum des Ereignisses von 10/06/2025 und identifiziert die meldende Person als Sanjeev Narula mit einer Adresse in 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Das Formular gibt an, dass die meldende Person ein Beamter mit dem Titel Finanz- und Geschäftsleiter ist. Der Bericht offenbart keine vorteilhaft gehaltenen nicht-derivativen oder derivativen Wertpapiere (aufgeführt als 0 und keine Wertpapiere sind vorteilhaft gehalten). Die Unterschrift auf dem Formular erfolgt durch einen Bevollmächtigten datiert auf 10/07/2025.

النموذج الأولي 3 مقدم للسنجيف نارولا. يتضمن الإيداع تاريخ الحدث البالغ 10/06/2025 ويحدد الشخص المبلغ ك سانجيف نارولا مع عنوان 100 Campus Drive, Suite 102, Florham Park, NJ 07932. يشير النموذج إلى أن الشخص المبلغ عنه هو موظف رسمي باللقب المدير المالي ومدير الأعمال. يذكر التقرير لا يوجد تمتلك أي وثائق مالية غير مشتقة ولا مشتقة بشكل استئساري (مُدرج كـ 0 و لا تمتلك أي أدوات مالية بشكل استئساري). التوقيع على الإيداع هو من قبل وكيل قانوني بتاريخ 10/07/2025.

Initial Form 3 提交给 Sanjeev Narula。 该申报中显示一个 Date of Event10/06/2025,并将申报人识别为 Sanjeev Narula,地址为 100 Campus Drive, Suite 102, Florham Park, NJ 07932。表格指出申报人是一名 Officer,职务为 Chief Financial & Bus. Officer(首席财务/业务官)。报告披露 非派生或派生证券的受益所有权(列为 0,且 无证券被受益所有)。申报的签字由一名 attorney-in-fact(代理律师/授权代理人)签署,日期为 10/07/2025

Positive
  • None.
Negative
  • None.

Modulo Iniziale 3 presentato per Sanjeev Narula. Il deposito riporta una Data dell'Evento di 10/06/2025 e identifica la persona che presenta la dichiarazione come Sanjeev Narula con un indirizzo in 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Il modulo indica che la persona che presenta la dichiarazione è un Officer con il titolo Direttore Finanziario e Responsabile delle Attività. Il rapporto dichiara nessuno di titoli non derivati o derivati detenuti in modo vantaggioso (elencati come 0 e nessun titolo è detenuto in modo vantaggioso). La firma della presentazione è di un procuratore ad acta datata 10/07/2025.

Formulario Inicial 3 presentado para Sanjeev Narula. La presentación informa una Fecha del Evento de 10/06/2025 e identifica a la persona informante como Sanjeev Narula con una dirección en 100 Campus Drive, Suite 102, Florham Park, NJ 07932. El formulario indica que la persona informante es un Funcionario con el título Director Financiero y de Negocios. El informe revela ninguna tenencia ventajosa de valores no derivados ni derivados (enumerados como 0 y ningún valor es ventajosamenteposeído). La firma del archivo es realizada por un apoderado con fecha 10/07/2025.

사니조브 나루라를 위한 초기 양식 3 제출. 제출서는 사건 날짜10/06/2025로 보고하며 보고자는 Sanjeev Narula로 식별되고 100 Campus Drive, Suite 102, Florham Park, NJ 07932에 주소가 있습니다. 양식은 보고자가 임원이며 직함은 재무 책임자 및 비즈니스 책임자임을 명시합니다. 보고서는 없음의 비파생 또는 파생 증권을 실질적으로 소유하지 않는다고 밝히며(목록에 0, 자산이 실질적으로 보유되지 않음으로 표시). 서명은 대리인2025-10-07자로 이루었습니다.

Formulaire initial 3 déposé pour Sanjeev Narula. Le dépôt indique une Date de l'Événement de 10/06/2025 et identifie la personne qui dépose comme Sanjeev Narula avec une adresse au 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Le formulaire indique que la personne déclarante est un Fonctionnaire avec le titre Directeur Financier et Responsable des Activités. Le rapport indique aucun titre détenu de manière bénéficiaire tant pour des valeurs non dérivées que dérivées (énumérés comme 0 et aucune valeur n’est détenue de manière bénéficiaire). La signature sur le dépôt est apposée par un mandataire daté du 10/07/2025.

Initial Form 3 eingereicht für Sanjeev Narula. Die Einreichung meldet ein Datum des Ereignisses von 10/06/2025 und identifiziert die meldende Person als Sanjeev Narula mit einer Adresse in 100 Campus Drive, Suite 102, Florham Park, NJ 07932. Das Formular gibt an, dass die meldende Person ein Beamter mit dem Titel Finanz- und Geschäftsleiter ist. Der Bericht offenbart keine vorteilhaft gehaltenen nicht-derivativen oder derivativen Wertpapiere (aufgeführt als 0 und keine Wertpapiere sind vorteilhaft gehalten). Die Unterschrift auf dem Formular erfolgt durch einen Bevollmächtigten datiert auf 10/07/2025.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Narula Sanjeev

(Last) (First) (Middle)
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102

(Street)
FLORHAM PARK NJ 07932

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/06/2025
3. Issuer Name and Ticker or Trading Symbol
Phathom Pharmaceuticals, Inc. [ PHAT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial & Bus. Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned. 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula 10/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the PHAT Form 3 filed by Sanjeev Narula report?

The Form 3 reports that Sanjeev Narula is an Officer titled Chief Financial & Bus. Officer and discloses no beneficial ownership of Phathom Pharmaceuticals common stock.

What is the Date of Event on the PHAT Form 3 for Sanjeev Narula?

The Date of Event is 10/06/2025.

Does the Form 3 show any securities owned by Sanjeev Narula for PHAT?

No. The filing states "No securities are beneficially owned" and lists the amount as 0 shares (Direct).

Who signed the Form 3 for Sanjeev Narula and when?

The signature block shows "/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula" dated 10/07/2025.

What address is listed for the reporting person on the PHAT Form 3?

100 Campus Drive, Suite 102, Florham Park, NJ 07932.
Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

PHAT Rankings

PHAT Latest News

PHAT Latest SEC Filings

PHAT Stock Data

823.66M
55.28M
4.2%
83.99%
18.57%
Biotechnology
Pharmaceutical Preparations
Link
United States
FLORHAM PARK